McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726

Article  CAS  PubMed  Google Scholar 

Shah SJ, Borlaug BA, Chung ES, Cutlip DE, Debonnaire P, Fail PS et al (2022) Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial. Lancet Lond Engl 399(10330):1130–1140

Article  Google Scholar 

Sun W, Zou H, Yong Y, Liu B, Zhang H, Lu J et al (2022) The RAISE trial: a novel device and first-in-man trial. Circ Heart Fail 15(4):e008362

Article  CAS  PubMed  Google Scholar 

Barker CM, Meduri CU, Fail PS, Chambers JW, Solet DJ, Kriegel JM et al (2022) Feasibility of a no-implant approach to interatrial shunts: preclinical and early clinical studies. Struct Heart J Heart Team 6(4):100078

Article  Google Scholar 

Paitazoglou C, Bergmann MW, Özdemir R, Pfister R, Bartunek J, Kilic T et al (2021) One-year results of the first-in-man study investigating the atrial flow regulator for left atrial shunting in symptomatic heart failure patients: the PRELIEVE study. Eur J Heart Fail 23(5):800–810

Article  PubMed  Google Scholar 

Rodés-Cabau J, Bernier M, Amat-Santos IJ, Ben Gal T, Nombela-Franco L, García Del Blanco B et al (2018) Interatrial shunting for heart failure: early and late results from the first-in-human experience with the V-Wave system. JACC Cardiovasc Interv 11(22):2300–2310

Article  PubMed  Google Scholar 

Shah SJ, Feldman T, Ricciardi MJ, Kahwash R, Lilly S, Litwin S et al (2018) One-year safety and clinical outcomes of a transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction in the reduce elevated left atrial pressure in patients with heart failure (REDUCE LAP-HF I) trial: a randomized clinical trial. JAMA Cardiol 3(10):968–977

Article  PubMed  PubMed Central  Google Scholar 

Kaye DM, Hasenfuß G, Neuzil P, Post MC, Doughty R, Trochu JN et al (2016) One-year outcomes after transcatheter insertion of an interatrial shunt device for the management of heart failure with preserved ejection fraction. Circ Heart Fail 9(12):e003662

Article  PubMed  PubMed Central  Google Scholar 

Rodés-Cabau J, Lindenfeld J, Abraham WT, Zile MR, Kar S, Bayés-Genís A, Eigler N, Holcomb R, Núñez J, Lee E, Perl ML, Moravsky G, Pfeiffer M, Boehmer J, Gorcsan J, Bax JJ, Anker S, Stone GW (2024) Interatrial shunt therapy in advanced heart failure: Outcomes from the open-label cohort of the RELIEVE-HF trial. Eur J Heart Fail 26(4):1078–1089. https://doi.org/10.1002/ejhf.3215. Epub 2024 Apr 1. PMID: 38561314

Article  CAS  PubMed  Google Scholar 

Anker SD, Usman MS, Anker MS, Butler J, Böhm M, Abraham WT et al (2023) Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension. Eur J Heart Fail 25(7):936–955

Article  PubMed  Google Scholar 

Corvia Medical. Re-evaluation of the corvia atrial shunt device in a precision medicine trial to determine efficacy in mildly reduced or preserved ejection fraction (ef) heart failure (Protocol #2201) [Internet]. clinicaltrials.gov; 2024 Feb [cited 2023 Dec 31]. Report No.: NCT05425459. Available from: https://clinicaltrials.gov/study/NCT05425459

UCSF. UCSF heart failure trial: alleviant ALLAY-HF study [Internet]. 2023 [cited 2024 May 12]. Available from: https://clinicaltrials.ucsf.edu/trial/NCT05685303

Edwards Lifesciences. A Randomized, Sham-controlled clinical trial for evaluation of the Edwards APTURE transcatheter shunt system (ALT-FLOW II) [Internet]. clinicaltrials.gov; 2023 Sep [cited 2023 Dec 31]. Report No.: NCT05686317. Available from: https://clinicaltrials.gov/study/NCT05686317